SUPPORT-T for Progressive Pulmonary Fibrosis and Caregivers

This study is testing a digital program called SUPPORT-T for people with Progressive Pulmonary Fibrosis (PPF) and their caregivers. PPF is a lung disease that gets worse over time. SUPPORT-T is a palliative care program, which means it focuses on improving comfort and quality of life. The program includes a 9-week digital app guided by a nurse and virtual support groups. We want to see if SUPPORT-T is easy to use, helpful, and accessible. You might be able to join if you are an adult (18 or older) with confirmed PPF and speak English or Spanish. Your caregiver can also join if they are an adult who provides you with support and speaks English. The study will measure how well people are prepared for their disease at 10 months. The current status of this study is unclear, but it plans to enroll 170 participants.

Study design
This is a pilot randomized controlled trial, meaning participants will be assigned by chance to either receive the SUPPORT-T program or enhanced usual care. It aims to enroll 170 participants.
What's involved
If you participate, you will receive the SUPPORT-T Educational Intervention biweekly through telehealth visits for 1-4 visits, and then biweekly contact from a nurse. The intervention includes a 9-week digital application and quarterly virtual support groups over one year.
Compensation
Not stated in the trial record.
Follow-up
The study will measure outcomes at 10 months after the intervention begins.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07269262

SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers

Recruiting
NAAges 18+InterventionalSupportive care
Medical University of South Carolina
~170 participants
Updated 2026-02-02 on ClinicalTrials.gov
What's tested:SUPPORT-T Educational Intervention

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility of Disease Preparedness
Measured over 10 months
+1 more outcome measured
Progressive Pulmonary Fibrosis
Interstitial Lung Disease
1 sites across 1 states
South Carolina1
Kathleen Lindell, PhD, RN, ATSF, FAAN
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Adults ≥18 years
Confirmed diagnosis of PPF
English or Spanish speaking
adult, ≥ 18 years old
Designated and identified by patient as providing most of the emotional, financial, and/or physical support (i.e., the individual most involved in care, does not have to live with patient)
Able to speak and understand English.
  • Feasibility of Disease Preparedness10 months

    Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.

  • Disease Preparedness Feasibility10 months

    Feasibility outcomes include number of participants recruited weekly, number of participants who declined, and number of participants who did not meet eligibility requirements, data collection procedures, and participant responses. Feasibility data will inform future studies on approaches for recruitment and retention, study procedures, and timing and participant capacity to complete surveys/interviews.